Alopexx - Crunchbase Company Profile & Funding

Q: Where is Alopexx's headquarters?

Alopexx is located in Concord, Massachusetts, United States.

Q: Who invested in Alopexx?

Alopexx is funded by Biotech Consortia.

Q: When was the last funding round for Alopexx?

Alopexx closed its last funding round on obfuscated from a Corporate Round round.

Overview

Alopexx

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Alopexx

CB Rank

546745

Alopexx partners with innovative entrepreneurs to build successful new companies. We will in-license novel therapies or medical devices

Founded

obfuscation

Private

Corporate Round

Concord, Massachusetts, United States

11-50

www.alopexx.com/

Biotechnology

Health Care

Medical

Pharmaceutical

Funding Rounds

Corporate Round

OBF

obfuscation

Key People

Daniel Vlock: Founder and CEO
Past Role: Harvard Medical School, Faculty
Daniel Vlock: Chief Medical Officer
Past Role: Harvard Medical School, Faculty

Details

Legal Name

Alopexx Enterprises, LLC

Operating Status

Active

Company Type

For Profit

Founders

Daniel Vlock

Phone Number

978-341-8183

Contact Email

cdelosreyes@alopexx.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

F598 Monoclonal Antibody

A fully human monoclonal antibody designed to provide immediate protection against microbial infections by targeting PNAG on pathogen surfaces.

AV0328 Vaccine

A chemically synthesized vaccine targeting PNAG to provide long-term protection against a broad range of microbial infections, complementing existing vaccines.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round
obfuscated obfuscation	Corporate Round - Alopexx	1	obfuscated obfuscation	Biotech Consortia	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Biotech Consortia	Yes	Corporate Round - Alopexx	—
Biotech Consortia	Yes	Corporate Round - Alopexx	—
Biotech Consortia	Yes	Corporate Round - Alopexx	—
Biotech Consortia	Yes	Corporate Round - Alopexx	—
Biotech Consortia	Yes	Corporate Round - Alopexx	—

Investments

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation

Investment Breakdown

Number of Investments

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation
obfuscated obfuscation	Cognoptix	—	Venture Round - Cognoptix	obfuscated obfuscation